ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1102

Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients Are Influenced By Adipokines

Lali Tsiklauri1, Janina Werner2, Klaus W. Frommer1, Ulf Müller-Ladner3, Stefan Rehart4, Sabine Wenisch2 and Elena Neumann1, 1Justus-Liebig-University Giessen, Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Bad Nauheim, Germany, Bad Nauheim, Germany, 2Justus-Liebig-University Giessen, Institute of Veterinary-Anatomy, -Histology and –Embryology, Clinic of Small Animals, Giessen Germany, Giessen, Germany, 3Department of Internal Medicine and Rheumatology, Justus-Liebig-University Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 4Orthopedic & Trauma Surgery, Agaplesion Markus-Hospital, Frankfurt, Frankfurt, Germany

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Adipokines, MSCs, osteoarthritis and osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Biology and Pathology of Bone and Joint - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis is characterized by bone loss, increased fracture risk and reduced regeneration ability. Age-related bone loss leading to osteoporosis correlates with increased bone marrow fat infiltration and is characterized by an inverse relationship between bone mass and bone marrow adiposity. Bone marrow adipose tissue releases immunmodulatory (e.g. adipokines) and matrix-degrading proteins (e.g. matrix metalloproteinases, MMP) which promote bone loss observed in osteoporosis and osteoarthritis. Bone marrow adipocytes share mesenchymal stem cell (MSC) as precursors with osteoblasts. Therefore, adipocyte-derived factors might influence differentiation of bone marrow-derived MSC and be involved in the shift of differentiation from osteoblasts to adipocytes observed in osteoporosis. The aim was to analyze the presence of adipokines in the bone marrow cavity and their effects on MSC differentiation.

Methods: Spongiosa from femoral heads containing bone marrow were collected (hip replacement of osteoarthritis patients or after osteoporotic femoral neck fracture). Primary spongiosa-derived mesenchymal stromal cells (hMSC) and commercially obtained ‘normal’ MSC were cultured in adipogenic and osteogenic media 3 weeks with/without adipokines. Adipogenic differentiation was confirmed using Oil Red O staining. Realtime PCR for adipokines, bone marker genes, TIMP, MMP as well as of bone samples was performed. Matrix produced was stained and quantified using Alizarin S. Proinflammatory factors were measured by ELISA.

Results: Visfatin and leptin level were increased in osteoporotic bone (n=14) vs. non-osteoporotic bone (n=13). Visfatin induced the secretion of proinflammatory factors during both, osteogenic and adipogenic differentiation but not leptin or resistin (IL-6, IL-8, MCP-1). While MMP2 was reduced by stimulation of all adipokines during osteogenesis (n=3), visfatin reduced MMP13 expression during osteogenic differentiation (e.g. day 21: -55-fold) as well as TIMP1, -2 and RunX2 (e.g. day 21: -2.86-fold) / -3.17-fold / -5.85-fold, respectively) while leptin and resistin did not affect these parameters. Visfatin significantly increased matrix production during osteogenic differentiation. During adipogenesis, visfatin but not leptin or resistin stimulation of hMSC significantly increased MMP13 (e.g. day 21: 72-fold).

Conclusion: Visfatin and leptin were increased and resistin reduced in osteoporotic bone. MMP production was specifically reduced by visfatin during adipogenesis. Therefore, visfatin might promote bone destruction during increased adipogenic differentiation in osteoporosis. Of note, the shift towards osteogenic differentiation may be beneficial as visfatin appears to reduce MMP production during osteogenesis. Leptin had no direct effects on MSC differentiation in vitro, but could indirectly modulate bone degradation by affecting inflammatory cells.


Disclosure: L. Tsiklauri, None; J. Werner, None; K. W. Frommer, None; U. Müller-Ladner, None; S. Rehart, None; S. Wenisch, None; E. Neumann, None.

To cite this abstract in AMA style:

Tsiklauri L, Werner J, Frommer KW, Müller-Ladner U, Rehart S, Wenisch S, Neumann E. Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients Are Influenced By Adipokines [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/differentiation-of-spongiosa-derived-mesenchymal-stromal-cells-from-osteoporosis-and-osteoarthritis-patients-are-influenced-by-adipokines/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differentiation-of-spongiosa-derived-mesenchymal-stromal-cells-from-osteoporosis-and-osteoarthritis-patients-are-influenced-by-adipokines/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology